Cargando…
Bullous Pemphigoid Following the Moderna mRNA-1273 Vaccine
As the onset of novel variants of the severe acute respiratory syndrome coronavirus 2 virus pushes policy-makers to push widespread vaccination efforts, it is likely that an increased number of severe cutaneous adverse reactions (SCARs) will present. Therefore, it is important to understand the pres...
Autores principales: | Desai, Amar D, Shah, Radhika, Haroon, Attiya, Wassef, Cindy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106564/ https://www.ncbi.nlm.nih.gov/pubmed/35573488 http://dx.doi.org/10.7759/cureus.24126 |
Ejemplares similares
-
Purpuric Rash and Thrombocytopenia After the mRNA-1273 (Moderna) COVID-19 Vaccine
por: Malayala, Srikrishna V, et al.
Publicado: (2021) -
When Bullous Pemphigoid Is Not Bullous Pemphigoid: The Importance of Going Beyond Direct Immunofluorescence
por: Hopkins, Christina R, et al.
Publicado: (2022) -
Dyshidrosiform Bullous Pemphigoid Triggered by COVID-19 Vaccination
por: Shanshal, Mohammed
Publicado: (2022) -
Combination Therapy of Plasma Exchange and Rituximab to Treat Cicatricial Pemphigoid and Bullous Pemphigoid
por: Kunadia, Anuj, et al.
Publicado: (2021) -
Dyshidrosiform Bullous Pemphigoid: Case Reports and Review
por: Cohen, Philip R
Publicado: (2020)